Back to search results

PhD Studentship: Micro RNA Regulation of Neural Crest Development (WHEELERG_U19MCETN2)

University of East Anglia - School of Biological Sciences

Qualification Type: PhD
Location: Norwich
Funding for: UK Students, EU Students
Funding amount: Tuition fees are covered for UK/EU rate only (£4,327 2019/20 rate). A living salary will be provided for each year of the scholarship.
Hours: Full Time
Placed On: 8th November 2019
Closes: 16th December 2019

Start date: 1 April 2020. Start date is flexible should there be a no-deal Brexit on 31 January 2020.

Closing date: 12.00pm, Monday 16 December 2019

Supervisor: Grant Wheeler

Project description: NEUcrest is an Innovative Training Network (ITN) project, funded by the European Union Horizon 2020 Programme. The neural crest (NC) is an essential stem cell population of the vertebrate embryos that gives rise to various tissues in the body such as the cranial facial cartilage, peripheral nervous system and pigment cells. NEUcrest focuses on integrating academic, clinical and industrial research for a better understanding of neural crest development and neural crest related diseases called Neurocristopathies. These pathologies are a major group of congenital diseases in human, and a heavy societal concern. The NEUcrest network comprises 20 partners in academia, industry and hospitals from seven European countries, gathered in a synergistic effort to advance knowledge and outreach about these diseases.

MicroRNAs (miRNAs) are short, non-coding RNAs around 22 nucleotides in length that inhibit gene expression by translational repression or by causing degradation of target mRNAs. Some genes associated with miRNA production are deleted in neurocristopathies (e.g. DGCR8 in DiGeorge Syndrome). We have identified two microRNAs (miR-196a and miR-219) expressed in the early neural crest.  Our preliminary studies show that knockdown of either miRNA in the model organism Xenopus tropicalis (African clawed frog) causes a loss of neural crest tissue and are therefore predicted to target genes involved in NC specification. In this project the student will identify potential targets of miR-196a and 219, validate possible targets using cell-based luciferase assays and knockout of target sites in specific genes by CRISPR/Cas9 and determine where miR-196a and 219 act in the gene regulatory network for NC development.

The student will gain skills in molecular biology, embryology, in vivo biology and chemical biology. In addition, training for transverse skills in outreach and industrial managements are deeply embedded in the ITN programme.

The start date is flexible and it will be possible for the successful candidate to start prior to 1 April 2020, but applicants should discuss this with Dr Wheeler in the first instance.

Interviews will be held week commencing 6 January 2020. 

Person Specification: 

Acceptable first degree in Biological sciences, Cell Biology, Genetics, and Molecular Biology.

The standard minimum entry requirement is 2:1. 

Funding notes: This project is awarded with a 3-year PhD scholarship through the Horizon 2020 Marie Skłodowska-Curie Actions - Innovative Training Networks (ITN) Programme (No. 860635, pending Grant Agreement Signature).  EU applicants are eligible to apply who have not been based in the UK for more than 12 months in the last 3 years.  Remuneration will be in line with the Marie Skłodowska-Curie guidelines (Early Stage Researchers, ITN).  For programme, funding information and eligibility criteria please visit:

Tuition fees are covered for UK/EU rate only (£4,327 2019/20 rate). A living salary will be provided for each year of the scholarship.

We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role:

Subject Area(s):


PhD tools
More PhDs from University of East Anglia

Show all PhDs for this organisation …

More PhDs like this
Join in and follow us

Browser Upgrade Recommended has been optimised for the latest browsers.

For the best user experience, we recommend viewing on one of the following:

Google Chrome Firefox Microsoft Edge